Population-based study of tamoxifen therapy and subsequent ovarian, endometrial, and breast cancers.

Cook, L S; Weiss, N S; Schwartz, S M; White, E; McKnight, B; Moore, D E; Daling, J R

Cook, L S; Weiss, N S; Schwartz, S M; White, E; McKnight, B; Moore, D E; Daling, J R.

Affiliation

Cook LS; Department of Epidemiology, University of Washington, Seattle, USA.

J Natl Cancer Inst ; 87(18): 1359-64, 1995 Sep 20.

Article in En | MEDLINE | ID: mdl-7658496

Subject(s)

Breast Neoplasms/drug therapy; Breast Neoplasms/prevention & control; Endometrial Neoplasms/chemically induced; Neoplasms, Second Primary/chemically induced; Ovarian Neoplasms/chemically induced; Tamoxifen/adverse effects; Adult; Aged; Aged, 80 and over; Case-Control Studies; Female; Humans; Middle Aged; Population Surveillance; Tamoxifen/therapeutic use; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Tamoxifen / Breast Neoplasms / Neoplasms, Second Primary / Endometrial Neoplasms Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: J Natl Cancer Inst Year: 1995 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links